Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Information Technology ETF Vanguard | VGT | Nov 29, 2024 | 622.25 | +0.89 |
Infosys ADR | INFY | Nov 29, 2024 | 22.07 | -2.95 |
InfuSystems | INFU | Nov 29, 2024 | 8.90 | +0.45 |
ING Group ADR | ING | Nov 29, 2024 | 15.45 | +1.18 |
Ingersoll Rand | IR | Nov 29, 2024 | 104.17 | +0.12 |
Ingevity | NGVT | Nov 29, 2024 | 48.57 | +1.76 |
Ingles Markets A | IMKTA | Nov 29, 2024 | 73.90 | +0.76 |
Ingram Micro Holding Corp | INGM | Nov 29, 2024 | 23.82 | 0.00 |
Ingredion | INGR | Nov 29, 2024 | 147.34 | +0.21 |
Inhibikase Therapeutics | IKT | Nov 29, 2024 | 2.92 | +6.96 |
Inhibrx Biosciences | INBX | Nov 29, 2024 | 15.26 | -2.37 |
InMed Pharmaceuticals | INM | Nov 29, 2024 | 4.29 | -0.23 |
InMode | INMD | Nov 29, 2024 | 19.53 | +0.21 |
INmune Bio | INMB | Nov 29, 2024 | 5.05 | +3.27 |
Innate Pharma ADR | IPHA | Nov 29, 2024 | 1.54 | +2.67 |
Inno Holdings | INHD | Nov 29, 2024 | 4.91 | +0.49 |
Innodata | INOD | Nov 29, 2024 | 41.08 | +7.17 |
Innospec | IOSP | Nov 29, 2024 | 118.61 | +0.81 |
InnovAge | INNV | Nov 29, 2024 | 4.87 | +1.46 |
Innovate | VATE | Nov 29, 2024 | 6.06 | +3.41 |
Innovation Beverage Group | IBG | Nov 29, 2024 | 1.18 | 0.00 |
Innovative Eyewear | LUCY | Nov 29, 2024 | 6.67 | +2.52 |
Innovative Industrial Properties | IIPR | Nov 29, 2024 | 109.02 | -0.14 |
Innovative Industrial Properties A Pref | IIPR-A | Nov 29, 2024 | 26.27 | 0.00 |
Innovative Solutions and Support | ISSC | Nov 29, 2024 | 7.76 | +0.26 |
Innovex International | INVX | Nov 29, 2024 | 16.27 | 0.00 |
Innovid | CTV | Nov 29, 2024 | 3.04 | 0.00 |
Innoviva | INVA | Nov 29, 2024 | 18.99 | -0.32 |
Innoviz Technologies | INVZ | Nov 29, 2024 | 0.76 | +7.14 |
InnSuites Hospitality | IHT | Nov 29, 2024 | 2.27 | +5.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.